Richard Svensson
Project manager at Department of Pharmacy; UDOPP
- Telephone:
- +46 18 471 47 44
- E-mail:
- richard.svensson@uu.se
- Visiting address:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postal address:
- Box 580
751 23 UPPSALA
Download contact information for Richard Svensson at Department of Pharmacy; UDOPP

Publications
Recent publications
-
Part of Archives of Toxicology, p. 1877-1901, 2026
- DOI for Extrapolation of in vitro effect concentrations to in vivo bioavailable concentrations using PBK modelling in humans for two classes of persistent and mobile compounds: triazoles and triazines
- Download full text (pdf) of Extrapolation of in vitro effect concentrations to in vivo bioavailable concentrations using PBK modelling in humans for two classes of persistent and mobile compounds: triazoles and triazines
-
Efficacy of mebendazole in the spontaneous NZBxNZWF1 animal model of systemic lupus erythematosus
Part of Scientific Reports, 2026
- DOI for Efficacy of mebendazole in the spontaneous NZBxNZWF1 animal model of systemic lupus erythematosus
- Download full text (pdf) of Efficacy of mebendazole in the spontaneous NZBxNZWF1 animal model of systemic lupus erythematosus
-
Part of Environmental Toxicology and Pharmacology, 2025
- DOI for The intracellular free concentration of endocrine disrupting chemicals enables translation between cell-free and cell-based estrogenic activity assays
- Download full text (pdf) of The intracellular free concentration of endocrine disrupting chemicals enables translation between cell-free and cell-based estrogenic activity assays
-
Part of EBioMedicine, 2024
- DOI for Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib
- Download full text (pdf) of Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib
-
Part of Journal of Medicinal Chemistry, p. 1380-1425, 2023
- DOI for Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold- Based DNA Gyrase Inhibitors with Potent Activity against Acinetobacter baumannii and Pseudomonas aeruginosa
- Download full text (pdf) of Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold- Based DNA Gyrase Inhibitors with Potent Activity against Acinetobacter baumannii and Pseudomonas aeruginosa
All publications
Articles in journal
-
Part of Archives of Toxicology, p. 1877-1901, 2026
- DOI for Extrapolation of in vitro effect concentrations to in vivo bioavailable concentrations using PBK modelling in humans for two classes of persistent and mobile compounds: triazoles and triazines
- Download full text (pdf) of Extrapolation of in vitro effect concentrations to in vivo bioavailable concentrations using PBK modelling in humans for two classes of persistent and mobile compounds: triazoles and triazines
-
Efficacy of mebendazole in the spontaneous NZBxNZWF1 animal model of systemic lupus erythematosus
Part of Scientific Reports, 2026
- DOI for Efficacy of mebendazole in the spontaneous NZBxNZWF1 animal model of systemic lupus erythematosus
- Download full text (pdf) of Efficacy of mebendazole in the spontaneous NZBxNZWF1 animal model of systemic lupus erythematosus
-
Part of Environmental Toxicology and Pharmacology, 2025
- DOI for The intracellular free concentration of endocrine disrupting chemicals enables translation between cell-free and cell-based estrogenic activity assays
- Download full text (pdf) of The intracellular free concentration of endocrine disrupting chemicals enables translation between cell-free and cell-based estrogenic activity assays
-
Part of EBioMedicine, 2024
- DOI for Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib
- Download full text (pdf) of Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib
-
Part of Journal of Medicinal Chemistry, p. 1380-1425, 2023
- DOI for Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold- Based DNA Gyrase Inhibitors with Potent Activity against Acinetobacter baumannii and Pseudomonas aeruginosa
- Download full text (pdf) of Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold- Based DNA Gyrase Inhibitors with Potent Activity against Acinetobacter baumannii and Pseudomonas aeruginosa
-
Part of Diabetes, p. 638-652, 2023
-
Part of Journal of Medicinal Chemistry, p. 3968-3994, 2023
- DOI for New Dual Inhibitors of Bacterial Topoisomerases with Broad-Spectrum Antibacterial Activity and In Vivo Efficacy against Vancomycin-Intermediate Staphylococcus aureus
- Download full text (pdf) of New Dual Inhibitors of Bacterial Topoisomerases with Broad-Spectrum Antibacterial Activity and In Vivo Efficacy against Vancomycin-Intermediate Staphylococcus aureus
-
Part of Nature Cancer, p. 156, 2022
- DOI for Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress
- Download full text (pdf) of Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress
-
Part of Biomedicine and Pharmacotherapy, 2022
- DOI for Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration
- Download full text (pdf) of Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration
-
Part of Nucleic Acids Research, 2022
- DOI for Monitoring drug–target interactions through target engagement-mediated amplification on arrays and in situ
- Download full text (pdf) of Monitoring drug–target interactions through target engagement-mediated amplification on arrays and in situ
-
Part of Chemistry - A European Journal, 2022
- DOI for Broad-Spectrum Antidote Discovery by Untangling the Reactivation Mechanism of Nerve-Agent-Inhibited Acetylcholinesterase
- Download full text (pdf) of Broad-Spectrum Antidote Discovery by Untangling the Reactivation Mechanism of Nerve-Agent-Inhibited Acetylcholinesterase
-
Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer
Part of Scientific Reports, 2020
- DOI for Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer
- Download full text (pdf) of Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer
-
Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy
Part of Nature Communications, 2020
- DOI for Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy
- Download full text (pdf) of Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy
-
Part of MedChemComm, p. 1966-1987, 2019
- DOI for Methyl sulfonamide substituents improve the pharmacokinetic properties of bicyclic 2-pyridone based Chlamydia trachomatis inhibitors
- Download full text (pdf) of Methyl sulfonamide substituents improve the pharmacokinetic properties of bicyclic 2-pyridone based Chlamydia trachomatis inhibitors
-
Part of Nature Communications, 2018
- DOI for A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
- Download full text (pdf) of A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
-
Part of Scientific Reports, 2018
- DOI for Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound
- Download full text (pdf) of Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound
-
Part of Bioorganic & Medicinal Chemistry Letters, p. 2446-2450, 2018
-
Part of PLOS ONE, 2018
- DOI for Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib
- Download full text (pdf) of Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib
-
N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors
Part of Journal of enzyme inhibition and medicinal chemistry (Print), p. 513-521, 2017
- DOI for N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors
- Download full text (pdf) of N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors
-
Part of Biochemistry, p. 3089-3098, 2017
-
Part of European Journal of Pharmaceutical Sciences, p. 345-351, 2017
-
Part of European Journal of Pharmaceutical Sciences, p. 533-540, 2017
-
Part of ACS Chemical Neuroscience, p. 1383-1392, 2016
-
Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1
Part of Journal of Medicinal Chemistry, p. 1140-1148, 2016
-
Thiazolino 2-Pyridone Amide Inhibitors of Chlamydia trachomatis Infectivity
Part of Journal of Medicinal Chemistry, p. 2094-2108, 2016
-
Part of ChemMedChem, p. 455-460, 2015
-
Part of European Journal of Medicinal Chemistry, p. 191-209, 2015
-
Part of Bioorganic & Medicinal Chemistry, p. 6595-6615, 2014
-
Novel Peptidomimetic Hepatitis C Virus NS3/4A Protease Inhibitors Spanning the P2–P1′ Region
Part of ACS Medicinal Chemistry Letters, p. 249-254, 2014
-
Part of ACS Medicinal Chemistry Letters, p. 1272-1277, 2014
-
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
Part of Nature, p. 215-221, 2014
-
Part of Cell, p. 313-328, 2014
-
Part of Journal of Medicinal Chemistry, p. 2746-2754, 2014
-
Part of Journal of Medicinal Chemistry, p. 1790-1801, 2014
-
Part of Journal of Medicinal Chemistry, p. 2690-2694, 2013
-
Part of Journal of Medicinal Chemistry, p. 4953-4965, 2013
-
Part of Journal of Medicinal Chemistry, p. 9861-9873, 2013
-
Part of Toxicology in Vitro, p. 1357-1376, 2013
-
Part of Antimicrobial Agents and Chemotherapy, p. 1012-1018, 2013
-
Part of Pharmaceutical research, p. 411-426, 2012
-
Integrated cell models for prediction of drug transport and drug metabolism in the human hepatocyte
Part of Drug metabolism reviews (Softcover ed.), p. 306-307, 2010